A three-day training workshop on public health epidemic intelligence and rapid risk assessment (EI/RRA), organised by the European Centre for Disease Prevention and Control (ECDC) under the EU Initiative on Health Security, concluded today in Chișinău, Moldova. The event brought together over 40 public health professionals from Moldova, Armenia, Azerbaijan, and Georgia, with additional facilitators from EU Member States, Eastern European and South Caucasus partner countries and the World Health Organization (WHO).
Between September and December 2024, four countries in the EU/EEA (Finland, Germany, Poland, and Spain) and the United Kingdom (UK) reported detections of a genetic cluster of circulating vaccine-derived poliovirus type 2 (cVDPV2) in sewage samples.
Carbapenem resistance in Enterobacterales, such as Klebsiella pneumoniae and Escherichia coli, poses a significant threat to patients and healthcare systems in European Union/European Economic Area (EU/EEA) countries.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5 - 11 April 2025 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), Influenza A(H5N1), chikungunya, Ebola and an overview of respiratory virus epidemiology in the EU/EEA.
This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long COVID’.
Report on the findings of a survey on testing strategies for HIV in blood, tissues and cell donors within the EU/EEA at the time of development of ECDC guidelines for the prevention of donor-derived transmission of human immunodeficiency virus (HIV) through SoHO.
ECDC has released an assessment on tick-borne encephalitis (TBE), focusing on the transmission risks of the TBE virus (TBEV) through substances of human origin (SoHO) such as blood, organs, tissues, and cells.
